Table 3.
Summary of Results of the Included Studies Reporting on Active Case Finding for Tuberculosis, 1990–February 2016a
| Region | Reference | Testing Modality | Active Tuberculosis | Latent Tuberculosis Infections | ||
|---|---|---|---|---|---|---|
| Uptake, % | Positivity Rate, % | Uptake, % | Positivity Rate, % | |||
| EU/EEA | Foschi, 2015 (43) | At entry; opt in | 81.4 | 9.8 | ||
| EU/EEA | García-Guerrero, 2010 (92) | At entry; opt in | 90.2 | 50.4 | ||
| EU/EEA | Martin, 2001 (57) | At entry; opt in | 82.5 | 0.2 | 82.5 | 41.3 |
| EU/EEA | Ruiz-Rodríguez, 2010 (81) | At entry; opt in | 11.6 | NR | ||
| EU/EEA | Solé, 2010 (93) | At entry; opt in | 100.0 | 49.3 | ||
| EU/EEA | Bös, 2011 (unpublished data) | At entry; opt in | 100.0 | NR | ||
| Non–EU/EEA | Bock, 2001 (104) | At entry; opt in | 75.0 | 7.2 | ||
| Non–EU/EEA | Puisis, 1996 (58) | At entry; opt in | 75.0 | 0.1 | ||
| Non–EU/EEA | Ritter, 2012 (59) | At entry; opt in | 77.3 | 2.3 | ||
| EU/EEA | Andreev, 2011 (70) | Entry and stay | NR | 0.3 | ||
| EU/EEA | Vera-Remartinez, 2014 (73) | Entry and stay | 100.0 | 44.9 | ||
| Non–EU/EEA | Bock, 1999 (72) | Entry and stay | NR | 18.0 | ||
| Non–EU/EEA | Miller, 2006 (71) | Entry and stay | NR | 0.03 | NR | 0.9 |
| EU/EEA | Babudieri, 2012 (61) | During stay | NR | 21.80 | ||
| EU/EEA | Fernandez-Prieto, 2010 (79) | During stay | 92.6 | 21.8 | ||
| EU/EEA | Gabbuti, 2010 (80) | During stay | 15.4 | 41.6 | ||
| EU/EEA | Ruiz-Rodríguez, 2010 (81) | During stay | 100.0 | 19.3 | ||
| EU/EEA | Sagnelli, 2012 (75) | During stay | 42.8 | 17.2 | ||
| EU/EEA | Vera, 2010 (82) | During stay | 90.2 | 50.4 | ||
| Non–EU/EEA | Kiter, 2003 (100) | During stay | 99.8 | 0.4 | ||
Abbreviations: EEA, European Economic Area; EU, European Union; NR, not reported.
a The date range was 1980–February 2016 for the Cochrane Database.